Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01646047 · ClinicalTrials.gov registry record · NA
Diabetes Visual Function Supplement Study
A NA study of Diabetes Mellitus, Type 2 and Diabetes Mellitus, Type 1, sponsored by ZeaVision.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT01646047: Completed NA study of Diabetes Mellitus, Type 2 and Diabetes Mellitus, Type 1, sponsored by ZeaVision.
NCT01646047 is a NA study of Diabetes Mellitus, Type 2 and Diabetes Mellitus, Type 1 that has completed, run by ZeaVision. The registered enrollment target is 70 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01646047, a NA study of Diabetes Mellitus, Type 2 and Diabetes Mellitus, Type 1, has completed, sponsored by ZeaVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the effects of a novel multi-component dietary supplement on the visual function and retinal structure of patients with diabetes with both no diabetic retinopathy and mild to moderate diabetic retinopathy. This is a placebo-controlled trial and neither subjects nor examiners will know if any given subject is taking active supplement or placebo. The hypothesis is that the supplement will improve visual function and retinal structure in subjects on active supplement
Primary Outcome
Change in contrast sensitivity, color vision and macular perimetry thresholds
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT multi-component nutritional supplement capsules
- DIETARY_SUPPLEMENT multi-component dietary supplement
Study Locations (1)
Washington
- Chous Eye Care Associates - Tacoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2012-05 |
| Est. Completion | 2014-09 |
| Phase | NA |
What the finished NCT01646047 record still lists
NCT01646047 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which multi-component nutritional supplement capsules is the first listed.
NCT01646047 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT01646047 about?
NCT01646047 is a clinical study titled "Diabetes Visual Function Supplement Study". This study will evaluate the effects of a novel multi-component dietary supplement on the visual function and retinal structure of patients with diabetes with both no diabetic retinopathy and mild to moderate diabetic retinopathy. This is a placebo-controlled trial and neither subjects nor examiners...
What is the current status of trial NCT01646047?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2012-05. Estimated completion is 2014-09.
What conditions does trial NCT01646047 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Non-Proliferative Diabetic Retinopathy.
What interventions are being tested in trial NCT01646047?
The interventions under investigation include: multi-component nutritional supplement capsules (DIETARY_SUPPLEMENT), multi-component dietary supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01646047?
This trial is sponsored by ZeaVision, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01646047 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01646047's enrollment target sits among peer trials
70 229th of 348 higher than 120 of 348 other Diabetes Mellitus, Type 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia